Mc Ilrath & Eck, LLC Charles River Laboratories International, Inc. Transaction History
Mc Ilrath & Eck, LLC
- $572 Million
- Q4 2024
A detailed history of Mc Ilrath & Eck, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 25 shares of CRL stock, worth $3,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 35
28.57%
Holding current value
$3,888
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$958 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$791 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$339 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$281 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$281 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.91B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...